Stark Warnings For Pharma On Preserving Trust And Overcoming Risk Aversion

Insights From Scrip’s Lifetime Achievement Winner Jeremy Levin

Industry veteran Jeremy Levin, the 2023 winner of the Scrip Awards Lifetime Achievement Award, speaks to In Vivo about what holds back innovation in the biopharma industry, new technologies and commitments needed to protect the future relationship between drug developers and patients.

Jeremy Levin
Jeremy Levin, chair and chief executive officer of Ovid Therapeutics

For 30 years, Jeremy Levin served as a physician, biotech venture capitalist, biotech entrepreneur, chair of the board of the Biotechnology Innovation Organization, and executive leader of both large and small biopharmaceutical companies. Today he is chair and CEO of Ovid Therapeutics, Inc., a public company developing novel medicines to treat epilepsies and seizure-related disorders.

Key Takeaways
  • Jeremy Levin, Scrip Awards Lifetime Achievement winner, emphasizes the need for the biopharma industry to rebuild trust with patients.

Born in South Africa, Levin moved during childhood with his family to the UK and, after gaining degrees from both...

More from Leadership

More from In Vivo